Borealis Ventures

News, insights, analysis and data

← Back to Borealis Ventures profile

Borealis Ventures related stories

All articles and analysis

  • AI in the boardroom
    FeaturedDavid Bogoslaw- 13 November 2025

    A new study finds 51 percent of the business leaders and board directors saying AI should be driving long-term strategic planning and 51 percent saying their boards recruited AI specialists in the last 12 months.

  • Cuddling up to the $157bn pet care market
    ManagersDavid Bogoslaw- 10 November 2025

    Amid increasing pet ownership, longer lifespans for cats and dogs and the trend to treat pets as family members, venture capitalists are betting on expanding market opportunities in animal health.

  • One Health Company rallies $10m
    News BriefsIris Dorbian- 4 November 2020

    One Health Company, a provider of precision medicine for dogs with cancer, has raised $10 million in financing.

  • Madrona leads Series A round for Ovation.io
    Iris Dorbian- 14 March 2019

    Cambridge, Massachusetts-based Ovation.io, a next-generation clinical informatics company, has raised $5 million in Series A funding. Madrona Venture Group led the round with participation from other investors that included Borealis Ventures, Nat Turner, Zach Weinberg, StagedotO and David Shaw.

  • Building Ventures debuts
    Iris Dorbian- 18 September 2018

    Building Ventures, an early-stage venture firm focused on sustainable companies, has launched. The Boston-based firm was co-founded by Jesse Devitte and Travis Connors, leaders of Borealis Ventures' built environment investment team.

  • Evox Therapeutics procures $45.4 mln Series B
    Iris Dorbian- 4 September 2018

    UK-based Evox Therapeutics Ltd, an exosome therapeutics company, has raised $45.4 million in Series B financing. Redmile Group led the round with participation from other investors that included GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford Sciences Innovation and Oxford University.

  • Compass Therapeutics closes $132 mln Series A
    Iris Dorbian- 12 July 2018

    Cambridge, Massachusetts-based Compass Therapeutics, a biotechnology company, has closed its $132 million Series A financing. OrbiMed Advisors led the round with participation from other investors that included F-Prime Capital, Cowen Healthcare Investments, Thiel Capital, Biomatics Capital, Ulysses Holdings, Borealis Ventures, Alexandria Venture Investments and Biomed Realty Ventures.

  • Geothermal energy startup Dandelion fetches $4.5 mln
    iris dorbian- 27 March 2018

    Geothermal energy startup Dandelion has raised $4.5 million in funding. New Enterprise Associates led the round with participation from BoxGroup, Daniel Yates, Ground Up, Borealis Ventures, Collaborative Fund and ZhenFund.